FDA Approves IntelePACS and InteleViewer Workstation for Digital Mammography
17 September 2007
Intelerad Medical Systems, a top-rated PACS vendor based in Montreal, is pleased to announce that the FDA has approved its IntelePACS™ and InteleViewer™ Workstation products for the interpretation of digital mammographic images.
Digital mammography represented a new 'indication for use' for IntelePACS under the guidelines by which the FDA allows products to be marketed. InteleViewer Workstation, the standalone version of the IntelePACS viewer InteleViewer Enterprise, is also covered by the approval.
"Intelerad is committed to regulatory and industry conformance," said Chris Henri, Executive Vice President at Intelerad. "We recognize that clinicians in mission-critical environments need to know that their PACS and diagnostic workstations are meeting the highest standards," added Henri.
